Borderline Products Under EU MDR: EC Manual v4 Clarifications for Product Classification

 MedTech Leading Voice | Weekly Rundown

September 21, 2025 | Issue 130 — Three Overlooked MedTech Evidence Engines

From the Editor ✍🏽

Classification clarity, lifecycle biological safety, and CE readiness lead this week—plus use-error-driven CAPA, risk-based biocomp, IEC 60601-1 must-knows, PMS trend reporting, ENISA cyber guidance, post-quantum crypto, LDT policy shifts, MDSAP Malaysia, Hainan RWE, and TGA export rules.

Featured Webinar - EU AI Act Countdown: Critical Actions Medical Device Companies Must Take Before 2027

Prohibited practices are banned in February 2025. High-risk AI compliance lands Aug 2027. This session provides device teams with a clear plan: book notified-body capacity early, lock change control that won’t trigger reassessment, secure LLM supplier documentation (Annex XI/XII), and establish data governance with validation and human oversight built in.

• Join Subject Matter Experts:Felicity Ellis (Scarlet, Notified Body), Cécile van der Heijden (Axon Lawyers), Ema Omeragic (AKRA TEAM).
• When: Sept. 30, 2025 — 4 PM CET / 10 AM ET • Where: Online (recording for all registrants)
• Register: https://www.linkedin.com/events/euaiactcountdown7373437941156573184/

💥 This Week’s Top Posts – In Brief

(In no special order)

• Matt Burton — Borderline & Classification Manual v4:new EU examples that influence device vs non-device calls and classification strategy. 
• Marina Daineko — ISO 10993-1 update:lifecycle biological safety and early material selection reinforced for planning and documentation. 
• Dr. Pallavi Dasgupta — CE Marking checklist:Annex V checkpoints and common oversights to prevent EU launch delays. 
• EU MDR Compliance — “use error” framing:shifts CAPA toward system and usability contributors to stop repeats. 
• Intrinsic Medical Group — risk-based biocompatibility:ties ISO 10993 plans to ISO 14971 risk decisions. 
• Leonard Eisner — IEC 60601-1 cheat sheet:nine essentials to keep electrical safety efforts focused. 
• Casus Consulting — PMSV trend reporting draft: early look at the Manufacturer Trend Report form shaping PMS expectations. 
• Christine P. Bump — FDA LDT rule rescission: implications for IVD definitions and regulatory plans. 
• Danny Van Roijen — ENISA cyber guidance:baseline practices to raise cyber hygiene across the health sector. 
• Martin King — NIST post-quantum KEM:steps toward crypto-agility for connected devices and backends.
• Sigrid Berge van Rooijen — AI bias:eight strategies to detect and mitigate bias in clinical AI. 
• Medical Device Authority Malaysia — MDSAP:recognition that can streamline approvals and trust signals in Malaysia. 
• Elaine T. — Hainan pilot:pathway for RWD to support NMPA submissions.
• Stefano Bolletta — TGA export guidance:updated rules for exporting medicines from Australia, commercial and non-commercial. 

📊 Featured Post — European Commission Borderline & Classification Manual v4 (via Matt Burton)

The lines just moved—v4 shifts device boundaries and puts classification decisions back on your desk this week.

Matt Burton spotlighted new examples that impact device vs non-device calls, Annex VIII rule selection, and downstream claims, labeling, and evidence plans. Act fast:

• Recheck borderline families and intended-use wording against v4; update Annex VIII rationales in tech docs.
• Align claims/IFU/labeling; prep notified-body talking points; cascade to CEP, PMS/PMCF, and UDI where impacted.
• Run a quick portfolio sweep and refresh your classification memo template with v4 references; brief RA, clinical, and marketing. 👉 Check out the post!

🔥 In case you missed it

400+ MedTech pros just learned the 4 moves that stop device failures before they happen.

Last week's "Closing the Blind Spots" webinar was packed with early-stage strategies that most teams discover way too late. We're talking about the kind of intel that turns "expensive lesson learned" into "saw that coming."

• Jay Vaishnav(Canon Medical Informatics) broke down building your regulatory story as you build the device
• Kelley Kendle (ClariMed) dropped the truth bomb about usability decisions getting locked in at design freeze
• Amelia Hufford(3Aware) showed how real-world evidence reveals the risks your trials will never catch
• Steven Levine(Living Heart Project) walked through gating with in silico models before building hardware

The teams that nail these 4 moves early don't just avoid costly redesigns—they ship faster, cleaner, and with way fewer surprises.

Watch the replay here(seriously, bookmark this one)

Sections ✅

🛡️ Regulatory Roundup by Martin King | September 15, 2025

New updates from:🔹 𝗘𝗨 𝗜𝗩𝗗𝗥 & 𝗠𝗗𝗥: The Commission’s targeted revision finally lands, with SME relief and legacy device provisions that shift the risk calculus for portfolio managers. If you’re still treating IVDR as a static framework, it’s time to recalibrate.🔹 𝗔𝗜 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻: The EU AI Act enters its final phase, and the implications for diagnostic algorithms and clinical decision support tools are profound. Risk classification, transparency, and conformity assessments are no longer theoretical.𝗚𝗹𝗼𝗯𝗮𝗹 𝗠𝗼𝘃𝗲𝘀:🔸 Egyptian Drug Authority mandates GS1 serialization—impacting supply chain traceability across MedTech SKUs.🔸 FDA launches new biosimilar analytics guidance and expands remote facility tools—reshaping inspection readiness.🔸 ANVISA and Swissmedic issue modeling and technical guidance that hint at a more harmonized future.🔸 European Commission 𝗕𝗼𝗿𝗱𝗲𝗿𝗹𝗶𝗻𝗲 𝗖𝗹𝗮𝘀𝘀𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀: Updates on dermal fillers, FeNO diagnostics, and Rule 11 calculators demand immediate SKU-level review.

👉 Powered by Hoodin.

📈 510(k)s at a Glance for the week of September 15, 2025

Marcus Engineering, LLC highlighted 70 new FDA 510(k) cleared devices last week, including 14 first-time 🚀 clearances.

👉 For full details, visit Marcus Engineering’s report.

📅 Upcoming Events

• 9/26 — "Human Factors Engineering in MedTech: Why Usability Matters From Day One," MLVx In-Focus with Kay Sim, ClariMed. Register
• 9/30 — "EU AI Act Countdown: Critical Actions Medical Device Companies Must Take Before 2027," MLV Webinar with AKRA TEAM (panel). Register
• 10/3 — "State of the Art – From Claims to Strategy," MLVx In-Focus with Robert van Boxteland Jelle Schrauwen. Register
• 10/3 — "FDA Strategy 2025 Policy Pressures and the Path to MedTech Clearance," MLV Webinar with Michelle Lott. Register

🐝 PS — Join me LIVE this week in Portugal for AI in Medtech 2025 - Summit and Retreat with Complear!